Insulin Pricing

Insulin Pricing

Articles tagged with "Insulin Pricing".

100 Years of Insulin: Why Is It So Expensive and What Can Be Done?

Tags: Insulin Pricing, Healthcare Policy, Patent Reform, Drug Affordability

October 26, 2025

Why Does Insulin Cost Hundreds of Dollars When It Was Discovered 100 Years Ago?

Despite being discovered in 1922 and costing pennies to manufacture, insulin now costs Americans $200-300 per vial due to patent manipulation strategies called “evergreening,” where pharmaceutical companies make minor modifications to extend exclusivity and prevent generic competition. This systematic exploitation of patent law has transformed Frederick Banting’s $1 gift to humanity into one of the most expensive medications in the world, forcing patients to ration life-saving treatment or face financial ruin.

Read more

Diabetes Drug Spending Tripled Between 2002-2013: The Data Behind Rising Costs

Tags: Diabetes Costs, Healthcare Spending, Insulin Pricing, Pharmaceutical Economics

October 26, 2025

How Much Did Diabetes Drug Spending Increase Between 2002 and 2013?

U.S. expenditures on antihyperglycemic medications skyrocketed from $6.7 billion in 2002 to $22.3 billion in 2013 - a 233% increase that far exceeded inflation, population growth, or diabetes prevalence changes. Insulin accounted for the largest portion of this spending growth, with costs rising from $1.2 billion to $6.0 billion during the same period, representing a 400% increase that transformed diabetes treatment from affordable to financially devastating for many patients.

Read more

Insulin in America: A Right or a Privilege?

Tags: Insulin Pricing, Healthcare Access, Medical Ethics, Drug Policy

October 26, 2025

Has Insulin Become a Privilege Rather Than a Right in America?

Despite Frederick Banting’s intention to make insulin freely available by selling the patent for just $1, insulin has become prohibitively expensive in the United States, with some patients paying over $300 per vial. This transformation of a life-saving medication from an affordable necessity to a luxury item represents a fundamental betrayal of the discoverer’s vision and raises critical questions about healthcare as a human right versus a market commodity.

Read more